Credit Suisse Ag Kiniksa Pharmaceuticals, Ltd. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Credit Suisse Ag holds 28,924 shares of KNSA stock, worth $615,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,924

Previous 28,924 -0.0%

Holding current value

$615,502

Previous $507,000 12.43%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$14.37 - $19.07 $50,524 - $67,050	3,516 Added 13.84%	28,924 $507,000
Q3 2023 Nov 13, 2023	SELL	$13.62 - $20.2 $79,636 - $118,109	-5,847 Reduced 18.71%	25,408 $441,000
Q2 2023 Aug 11, 2023	BUY	$10.44 - $16.48 $67,191 - $106,065	6,436 Added 25.93%	31,255 $440,000
Q1 2023 May 10, 2023	BUY	$10.7 - $15.79 $27,349 - $40,359	2,556 Added 11.48%	24,819 $267,000
Q4 2022 Feb 13, 2023	SELL	$11.42 - $17.05 $33,643 - $50,229	-2,946 Reduced 11.69%	22,263 $333,000
Q3 2022 Nov 10, 2022	BUY	$9.76 - $13.41 $74,703 - $102,640	7,654 Added 43.6%	25,209 $324,000
Q2 2022 Aug 12, 2022	SELL	$7.6 - $11.41 $15,124 - $22,705	-1,990 Reduced 10.18%	17,555 $170,000
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $2,287 - $3,043	246 Added 1.27%	19,545 $194,000
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $36,801 - $53,661	3,542 Added 22.48%	19,299 $226,000
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $8,565 - $12,204	752 Added 5.01%	15,757 $178,000
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $31,965 - $46,159	-2,418 Reduced 13.88%	15,005 $209,000
Q1 2021 May 14, 2021	SELL	$16.68 - $23.97 $579,396 - $832,621	-34,736 Reduced 66.6%	17,423 $322,000
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $600,776 - $858,541	40,593 Added 350.97%	52,159 $921,000
Q3 2020 Nov 13, 2020	SELL	$15.21 - $25.53 $231,268 - $388,183	-15,205 Reduced 56.8%	11,566 $177,000
Q2 2020 Aug 12, 2020	BUY	$15.08 - $26.0 $151,584 - $261,352	10,052 Added 60.12%	26,771 $682,000
Q1 2020 May 13, 2020	SELL	$11.0 - $19.76 $19,272 - $34,619	-1,752 Reduced 9.49%	16,719 $259,000
Q4 2019 Feb 12, 2020	BUY	$5.24 - $12.96 $2,410 - $5,961	460 Added 2.55%	18,471 $204,000
Q3 2019 Nov 12, 2019	BUY	$8.15 - $15.88 $146,789 - $286,014	18,011 New	18,011 $153,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $734M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account